Evaluation of the effect of pretransplant, high-dose intravenous vitamin C in prevention of delayed graft function after deceased kidney transplantatio
Phase 3
Recruiting
- Conditions
- Complications of kidney transplant.Complications of kidney transplantT86.1
- Registration Number
- IRCT20100111003043N13
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
First kidney transplantation
Brain death donor
Transplant recipient age 14 or more
Patient informed consent to enter the study
Exclusion Criteria
Hemochromatosis
ESRD due to hyperoxaluria
Multi-organ transplantation
Favism history
Preemptive kidney transplantation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dialysis in the first week after the kidney transplant. Timepoint: Daily in the first week after the kidney transplant. Method of measurement: Medical records review.;Serum creatinine. Timepoint: Daily in the first week after kidney transplant then monthly until three months. Method of measurement: Jaffe's reaction.;Urine volume in the first six hours after transplantation. Timepoint: The first six hours after transplantation. Method of measurement: Urine volume.
- Secondary Outcome Measures
Name Time Method Acute rejection episode in the first three months after transplantation. Timepoint: the first three months after transplantation. Method of measurement: Medical records review.